Shortage of ADHD Medication Adderall, FDA Reports
The U.S. Food and Drug Administration (FDA) announced on Wednesday that there is a shortage of the medication Adderall, which is commonly used to treat attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. The shortage is due to intermittent manufacturing delays at Teva, one of the companies that produces the medication. While other companies continue to produce amphetamine mixed salts, they are not producing enough to meet the demand in the United States.
Adderall is an FDA-approved medication for ADHD and narcolepsy. Until the supply is restored, the FDA recommends alternatives such as the extended-release version of amphetamine mixed salts. The agency has posted information online about current manufacturers and available product strengths and is monitoring the shortage while helping manufacturers resolve it. The FDA will continue to provide updates.
Patients should work with their doctors to determine the best treatment option during this shortage, according to a news release from the FDA’s Center for Drug Evaluation and Research.